Madrigal pharmaceuticals inc - qtrly loss per common share $1.39

Madrigal pharmaceuticals reports 2019 third quarter financial results and highlights.qtrly loss per common share $1.39.q3 revenue view $0.00 -- refinitiv ibes data.as of september 30, 2019, madrigal had cash, cash equivalents and marketable securities of $453.6 million.

MDGL Ratings Summary

MDGL Quant Ranking